Solarcaine lotion
Solarcaine lotion is a medicine authorised by Swissmedic under authorisation number 26146. The authorisation holder is Verfora SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 12 September 1960 and the authorisation is valid without a time limit. ATC code D04AB01 places the medicine in the group Antipruritics.
| Authorisation number | 26146 |
|---|---|
| Name | Solarcaine lotion |
| Full name | Solarcaine lotion, emulsion cutanée |
| Authorisation holder | Verfora SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | D04AB01 |
| First authorisation | 12 September 1960 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Solarcaine lotion, emulsion cutanée | D | 25 September 1995 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 46 | 85 | ml | D04AB01 | 10.01.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Solarcaine lotion authorised in Switzerland?
Yes. Solarcaine lotion is authorised by Swissmedic under authorisation number 26146, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Solarcaine lotion have?
Solarcaine lotion is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Solarcaine lotion?
The authorisation holder is Verfora SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.